Page last updated: 2024-10-30

losartan and Acute Brain Injuries

losartan has been researched along with Acute Brain Injuries in 3 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nozaki, T1
Ura, H1
Takumi, I1
Kobayashi, S1
Maru, E1
Morita, A1
Friedman, A1
Bar-Klein, G1
Serlin, Y1
Parmet, Y1
Heinemann, U1
Kaufer, D1
Viswanathan, M1
de Oliveira, AM1
Wu, RM1
Chiueh, CC1
Saavedra, JM1

Reviews

1 review available for losartan and Acute Brain Injuries

ArticleYear
Should losartan be administered following brain injury?
    Expert review of neurotherapeutics, 2014, Volume: 14, Issue:12

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Injuries; Humans; Losartan; Signal Transduction; Transfor

2014

Other Studies

2 other studies available for losartan and Acute Brain Injuries

ArticleYear
The angiotensin II type I receptor antagonist losartan retards amygdala kindling-induced epileptogenesis.
    Brain research, 2018, 09-01, Volume: 1694

    Topics: Amygdala; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Brain Injuries; Cerebral

2018
[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.
    Cellular and molecular neurobiology, 1994, Volume: 14, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiogra

1994